Patent · US Active

Anti-tigit antibodies and methods of use

US10017572B2 · kind B2 · utility

10Cited by
10References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 23, 2016
Grant dateJul 10, 2018
Priority date
Expiry dateSep 23, 2036

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides anti-TIGIT (T-cell immunoreceptor with Ig and ITIM domains) antibodies and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.